ReviewCurrent drug safety2025

Treatment of Tislelizumab-Induced Toxic Epidermal Necrolysis and Agranulocytosis: A Case Report and Literature Review.

Yanshi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.